SCHEMBL3157772

SCHEMBL3157772

CCOC(=O)CC(c1ccc(C(=O)OCC)cc1)c1c(O)c2ccccc2oc1=O

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 8/20 0.60
HSD17B10 Q99714 2/20 0.60
ALB P02768 2/20 0.60
ALDH1A1 P00352 2/20 0.60
VKORC1 Q9BQB6 2/20 0.60
KDM4E B2RXH2 1/20 0.60
PCSK7 Q16549 1/20 0.60
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
ADORA3 P0DMS8 1/20 0.60
CYP3A4 P08684 1/20 0.59
NQO1 P15559 2/20 0.55
NR1I2 O75469 1/20 0.54
NR3C1 P04150 1/20 0.54
ADRA1A P35348 1/20 0.54
KCNH2 Q12809 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1647664 0.93 NQO1 (0.65) CYP2C9HSD17B10ALBALDH1A1VKORC1
SCHEMBL1647638 0.91 CYP2C9 (0.72) CYP2C9HSD17B10ALBALDH1A1VKORC1
SCHEMBL5149511 0.86 CYP2C9 (0.50) CYP2C9HSD17B10ALBALDH1A1VKORC1
SCHEMBL5113240 0.83 CYP2C9 (0.69) CYP2C9HSD17B10ALBALDH1A1VKORC1
SCHEMBL1648307 0.81 ADORA3 (0.55) CYP2C9HSD17B10ALBALDH1A1VKORC1
SCHEMBL1648320 0.81 ADORA3 (0.70) CYP2C9HSD17B10ALBALDH1A1VKORC1
SCHEMBL5103750 0.81 CYP2C9 (0.66) CYP2C9HSD17B10ALBALDH1A1VKORC1
SCHEMBL4958903 0.81 ADORA3 (0.60) CYP2C9ALDH1A1KDM4EMEN1KMT2A
SCHEMBL6827699 0.81 CYP2C9 (0.57) CYP2C9HSD17B10ALBALDH1A1VKORC1
SCHEMBL5972176 0.81 CYP2C9 (0.69) CYP2C9HSD17B10ALBALDH1A1VKORC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161261-B1 Materials and methods for treating coagulation disorders ARMETHEON INC (US) 2013-08-28 EP disclosed
EP-2161261-A1 Materials and methods for treating coagulation disorders Aryx Therapeutics (US) 2010-03-10 EP disclosed
EP-1735296-B1 MATERIALS AND METHODS FOR TREATING COAGULATION DISORDERS ARYX THERAPEUTICS (US) 2009-12-09 EP disclosed